Paul Vauterin Moves from CTO to COO at BioLizard

Paul Vauterin Moves from CTO to COO at BioLizard

Embracing the next phase of AI-driven innovation in life sciences Paul Vauterin has transitioned from Chief Technology Officer (CTO) to Chief Operating Officer (COO) at BioLizard, reflecting a shift in focus towards helping organisations integrate AI into their...
BioLizard has been listed as a Trends Gazelle

BioLizard has been listed as a Trends Gazelle

As a fast-growing company, BioLizard has been recognised as one of the companies to watch in 2025!  This recognition is part of a joint initiative by Trends, Change the Game, and Kanaal Z, which closely monitors companies achieving the greatest growth based on value...
AI in biotech: Fashioning the future of R&D and IP

AI in biotech: Fashioning the future of R&D and IP

In today’s dynamic biotech and biomedicine sectors, the transformative power of artificial intelligence (AI) stands at the forefront in R&D. To leverage AI to its full potential, it’s key to understand the nuanced, strategic advancements it brings –...
BioLizard joins Da’s Geniaal consortium

BioLizard joins Da’s Geniaal consortium

Ghent, October 24th, 2023. We are happy to announce that BioLizard has joined the Da’s Geniaal consortium.   The Da’s Geniaal consortium aims to inspire youngsters between 10 and 14 years to take on more science and technology oriented studies, with a...